Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Brain/therapeutic use"'
Autor:
J. David Smeijer, Jeroen Koomen, Donald E. Kohan, John J.V. McMurray, George L. Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, James L. Januzzi, Dalane W. Kitzman, Daniel M. Kolansky, Hirofumi Makino, Vlado Perkovic, Sheldon Tobe, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J.L. Heerspink
Publikováno v:
JACC Heart Fail
JACC. Heart failure, 10(7), 498-507. ELSEVIER SCI LTD
JACC. Heart failure, 10(7), 498-507. ELSEVIER SCI LTD
BACKGROUND: The endothelin receptor antagonist atrasentan reduced the risk of kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease (CKD) in the SONAR (Study of Diabetic Nephropathy with Atrasentan) trial, although with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5cb0019ff35f8d70ca9f0ea04c8b5b
https://doi.org/10.1016/j.jchf.2022.03.004
https://doi.org/10.1016/j.jchf.2022.03.004
